TCRT- Alaunos Therapeutics, Inc.

Name: Alaunos Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Alaunos Therapeutics, Inc. (TCRT) has 5 insiders with recent SEC Form 4 filings, including 1 buy and 9 sells. TCRT is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Postma Robert W	43.9K	$113.2K	-
Dir	Vieser Jaime	32.3K	$83.4K	-
CEO	Weis Holger	13.7K	$35.3K	-
VP	Groenewald Ferdinand	10.8K	$27.8K	-
Dir	Jerman Michael Allen	9.6K	$24.7K	-

Activity

Buys and sells only

Transactions

10 filings · page 2

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Sep 1, 2021	Huang James	Director	Buy	100,000	$1.71	$171,000.00	+1,200%	-22.3%	+68.2%
Jan 8, 2021	Buck Jill	EVP, Gm Gene Therapy	Sell	27,894	$3.12	$87,029.28	-12.3%	-	-
Jan 8, 2021	Lafond Kevin G	SVP, Treasurer &CAO	Sell	18,020	$3.09	$55,681.80	-22.0%	-	-
Jan 8, 2021	Hadfield Robert	General Counsel And Secretary	Sell	26,500	$3.12	$82,680.00	-16.6%	-	-
Jan 4, 2021	De Groot Eleanor	EVP, Gm Cell Therapy	Sell	21,620	$2.72	$58,806.40	-9.5%	-	-
Jan 4, 2021	Cooper Laurence James Neil	President And CEO	Sell	105,693	$2.71	$286,428.03	-5.5%	-	-
Jan 2, 2020	De Groot Eleanor	EVP, Gm Cell Therapy	Sell	24,890	$4.55	$113,249.50	-12.5%	-	-
Jan 2, 2020	Mauney David M Md	President	Sell	22,394	$4.55	$101,892.70	-10.3%	-	-
Jan 2, 2020	Hadfield Robert	General Counsel And Secretary	Sell	16,853	$4.55	$76,681.15	-14.3%	-	-
Jan 2, 2020	Buck Jill	EVP, Gm Gene Therapy	Sell	27,923	$4.55	$127,049.65	-13.8%	-	-

← PrevPage 2Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC